🎁 Black Friday: up to 50% off of annual plans
Shanghai Labway Clinical Laboratory Co., Ltd (SHE:301060)
China flag China · Delayed Price · Currency is CNY
8.02
-0.49 (-5.76%)
Nov 20, 2026, 3:04 PM CST

SHE:301060 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
40.96-30.75-109.44-141.59617.32203.84
Depreciation & Amortization
75.3175.3177.9765.3678.2459.35
Other Amortization
27.827.825.6418.0820.0311.24
Loss (Gain) From Sale of Assets
1.231.23-5.88-1.930.36-1.04
Asset Writedown & Restructuring Costs
12.4912.4915.8911.07158.371.07
Loss (Gain) From Sale of Investments
-6.49-6.4912.171.77-3.13-10.17
Provision & Write-off of Bad Debts
4.884.8825.67130.6755.7715.26
Other Operating Activities
25.124.7972.576.05140.6767.51
Change in Accounts Receivable
117.95117.95218.811,061-1,522-298.03
Change in Inventory
32.1532.159.4314.84-273.180.69
Change in Accounts Payable
-5.61-5.61-121.58-604.36828.74173.11
Change in Other Net Operating Assets
0.940.9419.935.09--
Operating Cash Flow
340.88268.85216.31546.9984.17223.51
Operating Cash Flow Growth
-18.13%24.29%-60.45%549.88%-62.34%33.14%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-47.86-58.49-76.62-398.89-230.08-118.88
Sale of Property, Plant & Equipment
7.517.845.63.994.685.49
Cash Acquisitions
----11.1--
Divestitures
0.523.523.8-0-
Investment in Securities
-19.83-79.83-26.94395.94-296.9
Other Investing Activities
7.634.070.630.569.516.88
Investing Cash Flow
-52.03-122.88-68.58-398.5180.05-403.41

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-----4
Long-Term Debt Issued
-50122.93368.64198.01-
Total Debt Issued
-50122.93368.64198.014
Short-Term Debt Repaid
------2
Long-Term Debt Repaid
--149.54-236.09-186.68-35.45-18.77
Lease Payments
-13.74-13.74-14.37-18.03-17.45-18.77
Total Debt Repaid
-105.44-149.54-236.09-186.68-35.45-20.77
Net Debt Issued (Repaid)
-105.44-99.54-113.16181.96162.57-16.77
Issuance of Common Stock
-----158.55
Repurchase of Common Stock
-1.57-1.57-12.75-10.26--
Common Dividends Paid
-82.51-92.7-7.36-136.71-125.61-0.3
Dividends Paid
-82.51-92.7-7.36-136.71-125.61-0.3
Other Financing Activities
-26.35-79.92-46.999.7413.53-21.73
Financing Cash Flow
-215.88-273.73-180.2544.7350.48119.75

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.01-0.03--0.57-0.560.02
Net Cash Flow
72.96-127.79-32.52192.65314.15-60.12

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
293.02210.36139.7148.1-145.91104.63
Free Cash Flow Growth
-17.55%50.59%-5.68%---15.16%
Free Cash Flow Margin
23.67%14.53%8.02%8.85%-3.48%5.88%
Free Cash Flow Per Share
0.750.550.340.37-0.360.30
Levered Free Cash Flow
242.98203.96187.84207.16-378.7938.83
Unlevered Free Cash Flow
245.56207.97194.6212.26-373.540.87
Free Cash Flow After Leases
279.28196.62125.33130.08-163.3685.86

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
38.3550.4848.43121.5194.1477.25
Change in Working Capital
159.59159.59101.72457.5-983.47-123.55